Concord Medical Files Annual Report on Form 20-F for Fiscal 2024
Concord Medical Services Holdings (NYSE: CCM), a Chinese healthcare provider specializing in cancer treatment, research, education and prevention, has announced the filing of its annual report on Form 20-F for the fiscal year ended December 31, 2024 with the U.S. Securities and Exchange Commission.
The electronic copy of the Annual Report is accessible on Concord Medical's investor relations website and the SEC's website. Shareholders can request free hard copies of the audited financial statements through the company's investor relations portal.
Concord Medical Services Holdings (NYSE: CCM), un fornitore cinese di servizi sanitari specializzato nel trattamento, ricerca, educazione e prevenzione del cancro, ha annunciato il deposito del suo rapporto annuale sul modulo 20-F relativo all'esercizio chiuso al 31 dicembre 2024 presso la Securities and Exchange Commission degli Stati Uniti.
La copia elettronica del Rapporto Annuale è disponibile sul sito web delle relazioni con gli investitori di Concord Medical e su quello della SEC. Gli azionisti possono richiedere copie cartacee gratuite dei bilanci certificati tramite il portale delle relazioni con gli investitori della società.
Concord Medical Services Holdings (NYSE: CCM), un proveedor chino de servicios de salud especializado en tratamiento, investigación, educación y prevención del cáncer, ha anunciado la presentación de su informe anual en el Formulario 20-F correspondiente al ejercicio fiscal finalizado el 31 de diciembre de 2024 ante la Comisión de Bolsa y Valores de EE.UU.
La copia electrónica del Informe Anual está disponible en el sitio web de relaciones con inversores de Concord Medical y en la página de la SEC. Los accionistas pueden solicitar copias impresas gratuitas de los estados financieros auditados a través del portal de relaciones con inversores de la empresa.
Concord Medical Services Holdings (NYSE: CCM)은 암 치료, 연구, 교육 및 예방을 전문으로 하는 중국의 의료 서비스 제공업체로, 2024년 12월 31일 종료된 회계연도에 대한 연례 보고서(Form 20-F)를 미국 증권거래위원회(SEC)에 제출했다고 발표했습니다.
연례 보고서 전자 사본은 Concord Medical의 투자자 관계 웹사이트와 SEC 웹사이트에서 확인할 수 있습니다. 주주들은 회사의 투자자 관계 포털을 통해 감사된 재무제표의 무료 인쇄본을 요청할 수 있습니다.
Concord Medical Services Holdings (NYSE : CCM), un prestataire de soins de santé chinois spécialisé dans le traitement, la recherche, l’éducation et la prévention du cancer, a annoncé le dépôt de son rapport annuel sur le formulaire 20-F pour l’exercice clos le 31 décembre 2024 auprès de la Securities and Exchange Commission des États-Unis.
La copie électronique du rapport annuel est accessible sur le site des relations investisseurs de Concord Medical ainsi que sur celui de la SEC. Les actionnaires peuvent demander des exemplaires papier gratuits des états financiers audités via le portail des relations investisseurs de la société.
Concord Medical Services Holdings (NYSE: CCM), ein chinesischer Gesundheitsdienstleister, der sich auf Krebsbehandlung, Forschung, Bildung und Prävention spezialisiert hat, hat die Einreichung seines Jahresberichts auf Formular 20-F für das am 31. Dezember 2024 endende Geschäftsjahr bei der US-Börsenaufsichtsbehörde SEC bekannt gegeben.
Die elektronische Version des Jahresberichts ist auf der Investor-Relations-Website von Concord Medical sowie auf der Website der SEC zugänglich. Aktionäre können über das Investor-Relations-Portal des Unternehmens kostenlose gedruckte Exemplare der geprüften Finanzberichte anfordern.
- None.
- None.
About Concord Medical
Concord Medical Services Holdings Limited is a healthcare provider featuring a full cycle of premium oncology services including cancer diagnosis, treatment, education and prevention. The Company focuses on providing multidisciplinary cancer care in all aspects of oncology healthcare services in its cancer hospitals and equipping them with technologically advanced equipment such as the state-of-the-art proton therapy system. The Company is striving to improve the quality and accessibility of cancer care through its network of self-owned cancer hospitals and clinics as well as partnered hospitals across
Forward-Looking Statements
This announcement contains forward-looking statements. These forward-looking statements can be identified by words or phrases such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar expressions. Forward-looking statements are inherently subject to uncertainties and contingencies beyond the Company's control and based upon premises with respect to future business decisions, which are subject to change. A number of important factors could cause actual results to differ materially from those contained in any forward-looking statement. The Company does not undertake any obligation to update any forward-looking statement, except as required under applicable law.
View original content:https://www.prnewswire.com/news-releases/concord-medical-files-annual-report-on-form-20-f-for-fiscal-2024-302438385.html
SOURCE Concord Medical Services Holdings Limited
FAQ
Where can investors access Concord Medical's (CCM) 2024 annual report?
How can shareholders obtain a hard copy of CCM's 2024 financial statements?
What is Concord Medical's (CCM) primary business focus?
When did Concord Medical (CCM) file its 2024 Form 20-F?
